USE OF CYCLOUNDECADEPSIPEPTIDE COMPOUNDS

摘要

The present invention relates to cycloundecadepsipeptide compound analogues presenting mitochondrial permeability transition pore (MPTP) inhibitory activity and reduced cytotoxicity. The present invention further relates to a pharmaceutical composition containing cycloundecadepsipeptide compound and analogues for use in the treatment or prevention of cell death associated disorders or diseases, related to the MPTP opening.